Astellas Pharma Singapore Pte. Ltd. clinical trials
A country office of Astellas Pharma Inc
The registry lists 9 studies whose lead sponsor is Astellas Pharma Singapore Pte. Ltd.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 12, 2025.
Registry sponsor names on this page
- Astellas Pharma Singapore Pte. Ltd.9 studies
Something wrong with this grouping? Tell us on the Astellas Pharma Inc page.
Studies
Recruiting first, then most recently updated. Showing 9 of 9. All Astellas Pharma Inc studies →
- Using Gilteritinib to Keep People With Acute Myeloid Leukemia Cancer-free After a Stem Cell TransplantCompletedNCT06734585
Sponsor listed in the registry: Astellas Pharma Singapore Pte. Ltd.
- A Study of Real-world Treatment of Adults With Urothelial Cancer in South Korea and Saudi ArabiaCompletedNCT06505746
Sponsor listed in the registry: Astellas Pharma Singapore Pte. Ltd.
- A Study of ELIGARD® in Hormone-dependent Prostate Cancer PatientsCompletedNCT03035032Phase 4
Sponsor listed in the registry: Astellas Pharma Singapore Pte. Ltd.
- A Study on Anticholinergic Use: Attribution of Overactive Bladder (OAB) Medications to the Anticholinergic BurdenCompletedNCT03903094
Sponsor listed in the registry: Astellas Pharma Singapore Pte. Ltd.
- A Cross-sectional Internet Survey to Estimate Prevalence of Lower Urinary Tract Symptoms (LUTS)CompletedNCT02618421
Sponsor listed in the registry: Astellas Pharma Singapore Pte. Ltd.
- Non-interventional Study for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Oceania - ERADICATE StudyCompletedNCT03174457
Sponsor listed in the registry: Astellas Pharma Singapore Pte. Ltd.
- A Survey Evaluating Prevalence, Severity and Associated Factors in East Asian Women With Moderate-to-severe Menopause-related Vasomotor Symptoms (MR-VMS)CompletedNCT04553029
Sponsor listed in the registry: Astellas Pharma Singapore Pte. Ltd.
- Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia OceaniaCompletedNCT03602508
Sponsor listed in the registry: Astellas Pharma Singapore Pte. Ltd.
- A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and ChinaCompletedNCT03572231
Sponsor listed in the registry: Astellas Pharma Singapore Pte. Ltd.